Robert-von-Ostertag-Str. 15
14163 Berlin
+49 30 838 62450
pathologie@vetmed.fu-berlin.de
Angiogenesis is involved in several physiological and pathological events propelling major research efforts since decades. Currently, main focus lies in the field of regenerative medicine. However, the evaluation of in vitro angiogenesis still faces problems regarding reproducibility of results, presumably based on the heterogeneity of endothelial cells (ECs). Being categorized based on their angiogenic potency, vimentin (VIM) and triosephosphate isomerase (TPI) were exclusively found in angiogenic ECs and adenosylmethionine synthetase isoform type-2 (MAT2A) only in non-angiogenic ECs. This study examines the expression of those mentioned proteins and their relation to in vitro angiogenesis in human dermal microvascular endothelial cells (HDMECs). Therefore, two batches of HDMECs were long-term cultivated. Stimulation and quantification of angiogenesis was carried out according to the recently established all-in-one assay (2). A shRNA-mediated knockdown of VIM and TPI was performed separately. The mRNA expression of vascular endothelial growth factor receptor 1 (VEGFR-1) and 2 (VEGFR-2) and mRNA and protein expression of VIM, TPI and MAT2A were determined via RT-qPCR and Western Blot. VIM expression was highest in beginning stages, TPI ascendingly throughout and MAT2A in earliest and late stages of in vitro angiogenesis. VIM and TPI knockdown resulted in a deceleration of angiogenesis, respectively. Knockdown cells with higher VGEFR-1 expression displayed smaller decrease in cell density. Concluding that VIM expression seems to be important for angiogenic stages of sprouting and migration, TPI for most angiogenic stages and MAT2A for quiescence of cells. Knockdowns lead to the suggestion of VIM and TPI being essential proteins and having pro-angiogenic effects on ECs. Furthermore, cell population possessing higher proliferative power was shown to be more resistant to manipulation.
[1] Bahramsoltani M, Harms T, Drewes B, Plendl J (2013) Searching for markers to identify angiogenic endothelial cells: a proteomic approach, Clinical Hemorheology and Microcirculation:55, 255-69.
[2] Bahramsoltani M, De Spiegelaere W (2016). Quantitation of tumor angiogenesis in vitro: An all-in-one angiogenesis assay, Methods in Molecular Biology 1464: 185-191.